MANE Veradermics, Incorporated Common Stock

NYSE · Pharmaceuticals · View on SEC EDGAR ↗
$129.74
Price · Jul 2, 2026
Fundamentals as of May 12, 2026
52W Range
$32–$131
98% of range
Analyst Rating
STRONG BUY
10 analysts
Price Target
$133
+2% upside
P/E (TTM)
—
ROE
82.6%
Net Profit Margin
—

MANE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$129.74
Market Cap
—
P/E (TTM)
—
EPS (TTM)
$-111.91
Revenue (TTM)
—
Div Yield
—
ROE
82.6%
Debt/Equity
—
52W Range
$32 – $131

MANE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS $-111.91
2-point trend, -202.1%
2024-12-31 → 2025-12-31
Free Cash Flow $-72M
2025-12-31 → 2025-12-31
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MANE
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MANE
Peer Median
ROA
-67.2%
1.4%
ROE
82.6%
13.9%
ROIC
59.8%
—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MANE
Peer Median
Current Ratio
16.7
2.6
Quick Ratio
2.4
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MANE
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MANE
Peer Median
EPS (Diluted)
2-point trend, -202.1%
$-111.91
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MANE
Peer Median

MANE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 5 50.0%
  • Buy 4 40.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

5 analysts · 2026-07-05
Median target $135.00 +4.1%
Mean target $132.80 +2.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.65%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-1.32 $-0.67 -0.65%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MANE — — — — 82.6% —
LGND $3.74B 30.8 60.4% 46.4% 13.5% —
BLTE — — — — — —
DFTX $1.32B -6.5 212.0% — -71.0% —
AMRX — 57.3 8.1% 2.4% -80.0% 36.9%
INDV — 21.9 4.3% 17.0% -118.3% 80.2%
CRNX $4.45B -9.4 640.7% -6046.2% -43.0% —
EWTX $2.64B -15.2 — — -30.2% —
GPCR $14.78B -86.9 — — -12.3% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for MANE
Metric Trend 20252024
R&D Expense 2-point trend, +166.6% $62M $23M
SG&A Expense 2-point trend, +194.2% $10M $3M
Operating Expenses 2-point trend, +170.2% $72M $27M
Operating Income 2-point trend, -170.2% $-72M $-27M
Interest Income 2-point trend, +224.7% $2M $481.0K
Other Non-op 2-point trend, +711.0% $2M $290.0K
Pretax Income 2-point trend, -164.3% $-70M $-26M
Income Tax Flat — no change across 2 periods $0 $0
Net Income 2-point trend, -164.3% $-70M $-26M
EPS (Basic) 2-point trend, -202.1% $-111.91 $-37.05
EPS (Diluted) 2-point trend, -202.1% $-111.91 $-37.05
Shares (Basic) 2-point trend, +1.1% 744,991 736,933
Shares (Diluted) 2-point trend, +1.1% 744,991 736,933
EBITDA $-72M ·
Balance Sheet 18
Annual Balance Sheet data for MANE
Metric Trend 20252024
Cash & Equivalents 2-point trend, -59.0% $22M $53M
Prepaid Expense 2-point trend, +333.8% $11M $2M
Other Current Assets 2-point trend, +707.9% $307.0K $38.0K
Current Assets 2-point trend, +174.6% $152M $56M
PP&E (Net) 2-point trend, +22000.00 $22.0K $0
Total Assets 2-point trend, +174.8% $153M $56M
Accounts Payable 2-point trend, -5.4% $2M $2M
Accrued Liabilities 2-point trend, +182.6% $7M $2M
Current Liabilities 2-point trend, +94.0% $9M $5M
Capital Leases 2-point trend, +4000.00 $4.0K $0
Total Liabilities 2-point trend, +94.1% $9M $5M
Common Stock Flat — no change across 2 periods $1.0K $1.0K
Paid-in Capital 2-point trend, +212.8% $2M $750.0K
Retained Earnings 2-point trend, -150.7% $-123M $-49M
AOCI 2-point trend, +60000.00 $60.0K $0
Stockholders' Equity 2-point trend, -149.6% $-121M $-48M
Liabilities + Equity 2-point trend, +174.8% $153M $56M
Shares Outstanding 2-point trend, +1.7% 749,760 736,933
Cash Flow 8
Annual Cash Flow data for MANE
Metric Trend 20252024
Stock-based Comp 2-point trend, +476.0% $1M $250.0K
Operating Cash Flow 2-point trend, -202.3% $-72M $-24M
CapEx 2-point trend, +24000.00 $24.0K $0
Investing Cash Flow 2-point trend, -118858000.00 $-119M $0
Financing Cash Flow 2-point trend, +163.1% $159M $60M
Net Change in Cash 2-point trend, -185.1% $-31M $37M
Taxes Paid Flat — no change across 2 periods $0 $0
Free Cash Flow $-72M ·
Profitability 3
Annual Profitability data for MANE
Metric Trend 20252024
ROA -67.2% ·
ROE 82.6% ·
ROIC 59.8% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for MANE
Metric Trend 20252024
Current Ratio 16.7 ·
Quick Ratio 2.4 ·
Per Share 4
Annual Per Share data for MANE
Metric Trend 20252024
Book Value / Share $-161.40 ·
Cash Flow / Share $-96.11 ·
Cash / Share $29.03 ·
EPS (TTM) $-111.91 ·
Valuation (TTM) 1
Annual Valuation (TTM) data for MANE
Metric Trend 20252024
Net Income TTM $-70M ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Net Income $-70M$-26M
Diluted EPS $-111.91$-37.05
Balance Sheet
2025-12-312024-12-31
Current Ratio 16.7—
Quick Ratio 2.4—
Cash Flow
2025-12-312024-12-31
Free Cash Flow $-72M—

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.